McCormick (MKC) director reports dividend reinvestment share purchase in Form 4
Rhea-AI Filing Summary
McCormick & Company director reports routine dividend reinvestment. A reporting person serving as a director of McCormick & Co., Inc. acquired 16.91 shares of voting common stock on 10/28/2025 through dividend reinvestment, at a price of $66.92 per share. After this transaction, the director beneficially owns 6,686.452 shares of McCormick common stock in direct ownership. The filing is made on behalf of a single reporting person and is described as a dividend reinvestment transaction, indicating shares were added automatically rather than through an open-market trade.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did McCormick (MKC) report in this Form 4?
The filing reports that a McCormick & Co., Inc. director acquired 16.91 shares of voting common stock on 10/28/2025 through dividend reinvestment at $66.92 per share.
How many McCormick (MKC) shares does the director own after this transaction?
Following the reported dividend reinvestment, the director beneficially owns 6,686.452 shares of McCormick common stock in direct ownership.
What was the nature of the McCormick (MKC) insider transaction on 10/28/2025?
The transaction is identified as a dividend reinvestment, meaning cash dividends were automatically used to purchase additional McCormick common shares for the director.
Who signed the McCormick (MKC) Form 4 and in what capacity?
The Form 4 was signed by Jason E. Wynn acting as Attorney-in-Fact for the reporting person, indicating a power-of-attorney authorization to sign on the insider's behalf.
Is this McCormick (MKC) Form 4 filed for multiple insiders or just one?
The form is indicated as being filed by one reporting person, not by a group or multiple insiders.
Does this McCormick (MKC) Form 4 involve any derivative securities?
The section for derivative securities shows no derivative transactions reported in connection with this filing; only common stock acquired via dividend reinvestment is listed.